Summary of Bill HR 5397
Bill 118 HR 5397, also known as the Joe Fiandra Access to Home Infusion Act of 2023, aims to improve access to home infusion therapy for Medicare beneficiaries. Home infusion therapy involves the administration of medication through a needle or catheter at home, rather than in a hospital or clinic setting.
The bill seeks to address barriers that currently prevent Medicare beneficiaries from accessing home infusion therapy, such as limited coverage and reimbursement options. It would require Medicare to cover home infusion therapy services, including the necessary equipment and supplies, for eligible beneficiaries.
Additionally, the bill includes provisions to ensure that Medicare beneficiaries have access to a qualified home infusion provider who can safely administer the therapy. This would help to ensure that beneficiaries receive the care they need in the comfort of their own homes, rather than having to travel to a medical facility for treatment.
Overall, the Joe Fiandra Access to Home Infusion Act of 2023 aims to improve access to home infusion therapy for Medicare beneficiaries, ultimately improving their quality of life and reducing healthcare costs.